Schelling Chris 13D/13G Filings for Acer Therapeutics Inc. (ACER)

Schelling Chris 13D and 13G filings for Acer Therapeutics Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2022-12-02
4:02 pm
Purchase
2022-11-29 13D Acer Therapeutics Inc.
ACER
Schelling Chris 2,858,995
16.000%
907,626increase
(+46.51%)
Filing
2020-08-03
4:06 pm
Purchase
2020-07-24 13D Acer Therapeutics Inc.
ACER
Schelling Chris 1,951,369
17.300%
201,369increase
(+11.51%)
Filing